![](\"https:\/\/mms.businesswire.com\/media\/20260520428327\/en\/1668940\/5\/Bausch_Lomb_logo.jpg\"){kind=logo}
<\/a><\/a>VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2026 annual meeting of shareholders (the \u201cAnnual Meeting\u201d) held on May 20, 2026. The detailed results of the vote for the election of directors are set out below:<\/p><\/a><\/a>
\nName<\/b><\/p><\/td> | \nFor<\/b><\/p><\/td> | \nAgainst<\/b><\/p><\/td> | \nBroker Non-Votes<\/b><\/p><\/td><\/tr>\n \nEduardo Alfonso, M.D.<\/p><\/td> \n331,573,622<\/p><\/td> \n4,244,069<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nNathalie Bernier<\/p><\/td> \n331,522,655<\/p><\/td> \n4,295,036<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nSteven H. Collis<\/p><\/td> \n331,575,559<\/p><\/td> \n4,242,132<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nSarah B. Kavanagh<\/p><\/td> \n331,548,740<\/p><\/td> \n4,268,951<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nKaren L. Ling<\/p><\/td> \n331,533,402<\/p><\/td> \n4,284,289<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nJohn A. Paulson<\/p><\/td> \n331,537,843<\/p><\/td> \n4,279,848<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nRussel C. Robertson<\/p><\/td> \n331,561,696<\/p><\/td> \n4,255,995<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nThomas W. Ross, Sr.<\/p><\/td> \n331,556,884<\/p><\/td> \n4,260,807<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nBrenton L. Saunders<\/p><\/td> \n331,476,725<\/p><\/td> \n4,340,966<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n \nAndrew C. von Eschenbach, M.D.<\/p><\/td> \n331,499,049<\/p><\/td> \n4,318,642<\/p><\/td> \n11,452,072<\/p><\/td><\/tr>\n<\/table> \nAt the Annual Meeting, shareholders also approved, in a non-binding advisory vote, the compensation of the Company\u2019s named executive officers and appointed PricewaterhouseCoopers LLP as the Company\u2019s independent registered public accounting firm until the close of the Company's 2027 annual meeting of shareholders.<\/p> \nThe final vote tabulation on all matters voted on at the Annual Meeting will be filed with the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's SEDAR+ profile and on the Company\u2019s website at www.bausch.com<\/a>.<\/p> \nAbout Bausch + Lomb<\/b><\/p> \nOur mission is simple \u2013 we help people see better to live better, all over the world. For nearly two centuries we\u2019ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we\u2019re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com<\/a> and connect with us on Facebook<\/a>, Instagram<\/a>, LinkedIn<\/a>, X<\/a> and YouTube<\/a>.<\/p> \n\u00a9<\/sup> 2026 Bausch + Lomb<\/i><\/p> \nMedia:<\/b> |